Gollob Jared Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$15.54M

Insider Activity of Gollob Jared

According to the SEC Form 4 filings, Gollob Jared, being in a position of

  1. Chief Medical Officer at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 59815 shares for $5.29M,
    over all time since 2021-02-17, has bought 0 shares, and sold 426517 shares for $24.67M.

Biography of Gollob Jared

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,288,5013100

Comparison of Insiders on Amount of Buys and Sells

2026-03-04SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
4,895
0.0061%
$85.30$417,521+23.28%
2026-03-02SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
5,613
0.0068%
$88.93$499,148+17.62%
2025-12-08SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
49,307
0.0644%
$88.67$4.37M-7.32%
2025-10-15SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
59,576
0.0814%
$61.42$3.66M+35.01%
2025-10-13SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
3,114
0.0044%
$60.00$186,840+41.31%
2025-03-03SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
5,740
0.009%
$30.45$174,786+55.65%
2024-07-16SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
23,145
0.0578%
$45.81$1.06M-11.22%
2024-07-15SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
16,455
0.0405%
$45.15$742,925-4.33%
2024-03-04SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
3,344
0.0054%
$41.86$139,967-3.98%
2024-02-27SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
400
0.0007%
$45.00$18,000-4.89%
2024-02-09SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
46,137
0.0835%
$35.50$1.64M+12.6%
2023-03-02SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
1,298
0.0021%
$31.00$40,233-24.5%
2021-11-02SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
14,996
0.0303%
$63.22$948,063-50.1%
2021-11-01SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
42,497
0.0867%
$61.78$2.63M-48.28%
2021-03-15SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
20,610
0.0463%
$60.17$1.24M-13.14%
2021-03-11SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
9,390
0.0213%
$60.05$563,878-11.4%
2021-02-24SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
17,350
0.0386%
$50.91$883,342+2.99%
2021-02-23SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
38,570
0.0851%
$49.65$1.92M+4.68%
2021-02-22SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
18,208
0.0411%
$52.63$958,260+1.07%
2021-02-19SaleKymera Therapeutics, Inc.
KYMR
Chief Medical Officer
17,774
0.0401%
$55.09$979,118-3.49%
Total: 22
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.